Literature DB >> 16790529

Connective tissue growth factor/CCN2 stimulates actin disassembly through Akt/protein kinase B-mediated phosphorylation and cytoplasmic translocation of p27(Kip-1).

J K Crean1, F Furlong, D Mitchell, E McArdle, C Godson, F Martin.   

Abstract

Connective tissue growth factor (CTGF/CCN2) is a 38-kDa secreted protein, a prototypic member of the CCN family, which is up-regulated in many diseases, including atherosclerosis, pulmonary fibrosis, and diabetic nephropathy. We previously showed that CTGF can cause actin disassembly with concurrent down-regulation of the small GTPase Rho A and proposed an integrated signaling network connecting focal adhesion dissolution and actin disassembly with cell polarization and migration. Here, we further delineate the role of CTGF in cell migration and actin disassembly in human mesangial cells, a primary target in the development of renal glomerulosclerosis. The functional response of mesangial cells to treatment with CTGF was associated with the phosphorylation of Akt/protein kinase B (PKB) and resultant phosphorylation of a number of Akt/PKB substrates. Two of these substrates were identified as FKHR and p27(Kip-1). CTGF stimulated the phosphorylation and cytoplasmic translocation of p27(Kip-1) on serine 10. Addition of the PI-3 kinase inhibitor LY294002 abrogated this response; moreover, addition of the Akt/PKB inhibitor interleukin (IL)-6-hydroxymethyl-chiro-inositol-2(R)-2-methyl-3-O-octadecylcarbonate prevented p27(Kip-1) phosphorylation in response to CTGF. Immunocytochemistry revealed that serine 10 phosphorylated p27(Kip-1) colocalized with the ends of actin filaments in cells treated with CTGF. Further investigation of other Akt/PKB sites on p27(Kip-1), revealed that phosphorylation on threonine 157 was necessary for CTGF mediated p27(Kip-1) cytoplasmic localization; mutation of the threonine 157 site prevented cytoplasmic localization, protected against actin disassembly and inhibited cell migration. CTGF also stimulated an increased association between Rho A and p27(Kip-1). Interestingly, this resulted in an increase in phosphorylation of LIM kinase and subsequent phosphorylation of cofilin, suggesting that CTGF mediated p27(Kip-1) activation results in uncoupling of the Rho A/LIM kinase/cofilin pathway. Confirming the central role of Akt/PKB, CTGF-stimulated actin depolymerization only in wild-type mouse embryonic fibroblasts (MEFs) compared to Akt-1/3 (PKB alpha/gamma) knockout MEFs. These data reveal important mechanistic insights into how CTGF may contribute to mesangial cell dysfunction in the diabetic milieu and sheds new light on the proposed role of p27(Kip-1) as a mediator of actin rearrangement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790529     DOI: 10.1096/fj.05-5010fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

1.  Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.

Authors:  Da Yong Lee; Tu-Hsueh Yeh; Ryan J Emnett; Crystal R White; David H Gutmann
Journal:  Genes Dev       Date:  2010-09-28       Impact factor: 11.361

2.  p27(KIP1) regulates neurogenesis in the rostral migratory stream and olfactory bulb of the postnatal mouse.

Authors:  Xuekun Li; Xiaobing Tang; Beata Jablonska; Adan Aguirre; Vittorio Gallo; Marla B Luskin
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

3.  Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth.

Authors:  Hongbo Lu; Kensuke Kojima; Venkata Lokesh Battula; Borys Korchin; Yuexi Shi; Ye Chen; Suzanne Spong; Deborah A Thomas; Hagop Kantarjian; Richard B Lock; Michael Andreeff; Marina Konopleva
Journal:  Ann Hematol       Date:  2013-10-24       Impact factor: 3.673

4.  Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

Authors:  Roger M Mason
Journal:  J Cell Commun Signal       Date:  2009-02-14       Impact factor: 5.782

5.  Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 gene.

Authors:  Hembindu Chintala; Haibo Liu; Rahul Parmar; Monika Kamalska; Yoon Ji Kim; David Lovett; Maria B Grant; Brahim Chaqour
Journal:  J Biol Chem       Date:  2012-10-09       Impact factor: 5.157

6.  Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis.

Authors:  Bryce G Johnson; Lan T Dang; Graham Marsh; Allie M Roach; Zebulon G Levine; Anthony Monti; Deepak Reyon; Lionel Feigenbaum; Jeremy S Duffield
Journal:  J Clin Invest       Date:  2017-10-09       Impact factor: 14.808

7.  Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype.

Authors:  Arnaud Besson; Harry C Hwang; Samantha Cicero; Stacy L Donovan; Mark Gurian-West; Dianna Johnson; Bruce E Clurman; Michael A Dyer; James M Roberts
Journal:  Genes Dev       Date:  2007-07-12       Impact factor: 11.361

8.  Promotion of Ccn2 expression and osteoblastic differentiation by actin polymerization, which is induced by laminar fluid flow stress.

Authors:  Tadashi Honjo; Satoshi Kubota; Hiroshi Kamioka; Yasuyo Sugawara; Yoshihito Ishihara; Takashi Yamashiro; Masaharu Takigawa; Teruko Takano-Yamamoto
Journal:  J Cell Commun Signal       Date:  2012-09-07       Impact factor: 5.782

Review 9.  Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis?

Authors:  Tri Q Nguyen; Roel Goldschmeding
Journal:  Pharm Res       Date:  2008-02-12       Impact factor: 4.200

10.  miR-205 expression promotes cell proliferation and migration of human cervical cancer cells.

Authors:  Hong Xie; Yungang Zhao; Stefano Caramuta; Catharina Larsson; Weng-Onn Lui
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.